Keyphrases
MiR-1179
100%
Diagnostic Biomarker
66%
Potential Biomarkers
56%
MiR-526b-3p
50%
Cervical Dystonia
50%
Brain-derived Neurotrophic Factor
50%
Liver Morphology
50%
MAPK6
50%
Small Interfering RNA (siRNA)
50%
Lipopolysaccharide
50%
Neurological Diseases
50%
Nanocoating
50%
Antibacterial Properties
50%
Juvenile Myoclonic Epilepsy
50%
Copper Oxide Nanoparticles (CuO NPs)
50%
Breast Cancer Treatment
50%
Anticorrosive Properties
50%
PLGA Nanoparticles
50%
Liver Function
50%
Anticancer Effect
50%
Harmful Effects
50%
SS316L
50%
Aspartame
50%
MicroRNA
48%
High Dose
37%
Epilepsy
36%
PLGA NPs
35%
Expression Level
29%
Healthy Controls
23%
Neuroinflammation
20%
C-reactive Protein
20%
Lactate Dehydrogenase
20%
Blood Samples
18%
Breast Cancer
14%
MCF-7 Cells
14%
Biomedical Applications
14%
Aspartate Transaminase
12%
Associated Genes
12%
Superoxide Dismutase
12%
Clinical Samples
11%
Receiver Operating Characteristic Curve
11%
Altered Expression
11%
Receiver Operating Characteristic Analysis
11%
Area under the Curve
11%
Peripheral Blood
11%
Diagnostic Value
11%
Quantitative PCR
11%
C-reactive Protein Level
10%
Neurological Disorders
10%
Blood-brain Barrier Disruption
10%
